StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Eli Lilly and Company
NYSE:LLY
Sector
Location
Market Cap
USD 697.04 B
Share Price
USD 776.44
Avg Daily Volume
4,009,380
Change (1 day)
1.87%
Change (1 year)
-10.34%
Change (YTD)
0.57%
Eli Lilly and Company EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 29.48%
Eli Lilly and Company EBIT Margin is 29.48% for the Trailing 12 Months (TTM) ending March 31, 2025, a 30.38% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Eli Lilly and Company EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 22.61%, a -5.60% change year over year.
-
Eli Lilly and Company EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 23.95%, a -0.66% change year over year.
-
Eli Lilly and Company EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 24.11%, a -16.76% change year over year.
-
Eli Lilly and Company EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 28.96%, a 0.99% change year over year.
Competitors
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
Cencora, Inc.
USD 292.97
COR
+0.30
0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%
Haleon plc
USD 4.80
HLN.L
+0.02
0.48%
Daiichi Sankyo Company, Limited
USD 24.77
4568.T
+0.95
3.97%
Ucb S.A.
USD 202.82
UCB.BR
+0.24
0.12%
BeOne Medicines Ltd.
USD 295.59
ONC
+3.66
1.25%
Hansoh Pharmaceutical Group Company Limited
USD 4.60
3692.HK
+0.03
0.70%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
Cencora, Inc.
USD 292.97
COR
+0.30
0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%
Haleon plc
USD 4.80
HLN.L
+0.02
0.48%
Daiichi Sankyo Company, Limited
USD 24.77
4568.T
+0.95
3.97%
Ucb S.A.
USD 202.82
UCB.BR
+0.24
0.12%
BeOne Medicines Ltd.
USD 295.59
ONC
+3.66
1.25%
Hansoh Pharmaceutical Group Company Limited
USD 4.60
3692.HK
+0.03
0.70%